Clinical Trial Update: Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults [Phase 4]

View source ↗

Summary

Phase 4 study comparing immunogenicity and safety of inactivated versus live attenuated hepatitis A vaccines in young adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Inactivated hepatitis A vaccine (Hepatitis A vaccine, inactivated)
• Live-attenuated hepatitis A vaccine (Hepatitis A vaccine, live-attenuated)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hepatitis A | Phase 4 | Status: COMPLETED